Cessation of oral anticoagulants in antiphospholipid syndrome

MLA

M-F Thiercein-Legrand, et al. “Cessation of Oral Anticoagulants in Antiphospholipid Syndrome.” Lupus, vol. 26, no. 12, Mar. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f7af01271121e40df568bf559f1c445&authtype=sso&custid=ns315887.

APA

M-F Thiercein-Legrand, Y Nguen, S Monnier, D Khau, Cécile Goujard, Françoise Sarrot-Reynauld, A Elmaleh-Sachs, M de Menthon, J-C Piette, Olivier Decaux, H Hyvernat, Gaëlle Leroux, Cloé Comarmond, Isabelle Marie, A Michon, Patrice Cacoub, E Oziol, Arsène Mekinian, T Fraisse, … D. Saadoun. (2017). Cessation of oral anticoagulants in antiphospholipid syndrome. Lupus, 26(12).

Chicago

M-F Thiercein-Legrand, Y Nguen, S Monnier, D Khau, Cécile Goujard, Françoise Sarrot-Reynauld, A Elmaleh-Sachs, et al. 2017. “Cessation of Oral Anticoagulants in Antiphospholipid Syndrome.” Lupus 26 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f7af01271121e40df568bf559f1c445&authtype=sso&custid=ns315887.